CoreCap Advisors »

Nls Pharmaceutics shares owned by CoreCap Advisors

Quarter-by-quarter ownership of Nls Pharmaceutics shares owned by CoreCap Advisors from 13F filings

Historical chart of CoreCap Advisors investment in Nls Pharmaceutics

Tip: Access up to 7 years of quarterly data

All positions including Nls Pharmaceutics held by CoreCap Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nls Pharmaceutics by CoreCap Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $65 36 1.83
2025-06-30 $104 36 2.89

More positions owned by CoreCap Advisors

Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Vanguard Total Stock Market Etf Etf (VTI)
Vanguard Total Bond Market Etf Etf (BND)
Technology Select Sector Spdr Fund Etf (XLK)
Vanguard S&p 500 Etf Etf (VOO)
Invesco Qqq Trust Series I Etf (QQQ)
Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Nvidia Corporation Stock (NVDA)
Goldman Sachs Marketbeta U.s. Equity Etf Etf (GSUS)
Apple Stock (AAPL)
Schwab U.s. Small-cap Etf Etf (SCHA)
Ishares Core S&p 500 Etf Etf (IVV)
Spdr S&p 500 Etf Trust Etf (SPY)
Vanguard Growth Etf Etf (VUG)
Invesco S&p 500 Equal Weight Etf Etf (RSP)

View all positions for CoreCap Advisors

Top funds holding Nls Pharmaceutics

CoreCap Advisors

View all funds holding Nls Pharmaceutics